BCAX - Company ID 0002023658
As of 2026-11-06, Bicara Therapeutics Inc. (BCAX) has a market capitalization of $563.13 M, making it the #2636 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $563.13 M |
| 2026-11-05 | $541.96 M |
| 2026-11-04 | $578.02 M |
| 2026-11-03 | $601.51 M |
| 2026-11-02 | $524.75 M |
| 2026-11-01 | $599.88 M |
| 2026-10-31 | $599.88 M |
| 2026-10-30 | $572.61 M |
| 2026-10-29 | $639.30 M |
| 2026-10-28 | $631.41 M |
| 2026-10-27 | $1.15 B |
| 2026-10-26 | $1.11 B |
As of 2026-11-06, Bicara Therapeutics Inc. (BCAX) has a market capitalization of $563.13 M, making it the #2636 most valuable US-listed company.
Bicara Therapeutics Inc. is the #2636 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $1.12 B |
| 2026-10-24 | $1.12 B |
| 2026-10-23 | $1.12 B |
| 2026-10-22 | $1.15 B |
| 2026-10-21 | $1.18 B |
| 2026-10-20 | $1.21 B |
| 2026-10-19 | $1.15 B |
| 2026-10-18 | $1.10 B |
| 2026-10-17 | $1.10 B |
| 2026-10-16 | $1.10 B |
| 2026-10-15 | $1.16 B |
| 2026-10-14 | $1.14 B |
| 2026-10-13 | $1.14 B |
| 2026-10-12 | $1.14 B |
| 2026-10-11 | $1.15 B |
| 2026-10-10 | $1.15 B |
| 2026-10-09 | $1.15 B |
| 2026-10-08 | $1.13 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.